X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Cadila Healthcare with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs TEVA PHARMA (Israel) - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CADILA HEALTHCARE   TEVA PHARMA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
TEVA PHARMA
Dec-13
CADILA HEALTHCARE/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs5582,929-   
Low Rs3622,545-   
Sales per share (Unadj.) Rs116.31,681.2-  
Earnings per share (Unadj.) Rs17.9105.0-  
Cash flow per share (Unadj.) Rs23.1240.9-  
Dividends per share (Unadj.) Rs3.5091.94-  
Dividend yield (eoy) %0.83.4 22.7%  
Book value per share (Unadj.) Rs85.41,867.5-  
Shares outstanding (eoy) m1,023.74848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.01.6 242.8%   
Avg P/E ratio x25.726.1 98.7%  
P/CF ratio (eoy) x19.911.4 174.9%  
Price / Book Value ratio x5.41.5 367.2%  
Dividend payout %19.687.5 22.4%   
Avg Mkt Cap Rs m470,6642,320,993 20.3%   
No. of employees `00011.844.9 26.3%   
Total wages/salary Rs m18,5450-   
Avg. sales/employee Rs Th10,072.731,719.6 31.8%   
Avg. wages/employee Rs Th1,569.10-   
Avg. net profit/employee Rs Th1,547.71,981.5 78.1%   
INCOME DATA
Net Sales Rs m119,0491,425,637 8.4%  
Other income Rs m1,1320-   
Total revenues Rs m120,1811,425,637 8.4%   
Gross profit Rs m28,475390,411 7.3%  
Depreciation Rs m5,388115,236 4.7%   
Interest Rs m91128,002 3.3%   
Profit before tax Rs m23,308247,174 9.4%   
Minority Interest Rs m6281,123 55.9%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-162,256 0.0%   
Tax Rs m5,644-3,018 -187.0%   
Profit after tax Rs m18,29289,058 20.5%  
Gross profit margin %23.927.4 87.3%  
Effective tax rate %24.2-1.2 -1,983.4%   
Net profit margin %15.46.2 246.0%  
BALANCE SHEET DATA
Current assets Rs m82,005962,870 8.5%   
Current liabilities Rs m60,720839,704 7.2%   
Net working cap to sales %17.98.6 207.0%  
Current ratio x1.41.1 117.8%  
Inventory Days Days7391 80.5%  
Debtors Days Days9896 102.5%  
Net fixed assets Rs m83,703465,644 18.0%   
Share capital Rs m1,0243,509 29.2%   
"Free" reserves Rs m86,4210-   
Net worth Rs m87,4451,583,612 5.5%   
Long term debt Rs m25,551728,960 3.5%   
Total assets Rs m180,6533,258,036 5.5%  
Interest coverage x26.69.8 270.5%   
Debt to equity ratio x0.30.5 63.5%  
Sales to assets ratio x0.70.4 150.6%   
Return on assets %10.63.6 295.8%  
Return on equity %20.95.6 372.0%  
Return on capital %22.04.9 445.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m31,4410-   
CASH FLOW
From Operations Rs m9,193227,173 4.0%  
From Investments Rs m-9,737-80,496 12.1%  
From Financial Activity Rs m515-272,509 -0.2%  
Net Cashflow Rs m-29-125,833 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 70.18 Rs / USD

Compare CADILA HEALTHCARE With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare CADILA HEALTHCARE With: DISHMAN PHARMA  DR. DATSONS LABS  TORRENT PHARMA  AUROBINDO PHARMA  GLENMARK PHARMA  



Today's Market

Of Mutual Funds Off Loading Small Caps, Depreciating Rupee and Key Stocks in Action Today(Pre-Open)

There is an interesting dichotomy in the Indian markets these days. On one hand the BSE Sensex is touching life time highs.

Related Views On News

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Up 274.4% (Quarterly Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

For the quarter ended June 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (up 274.4% YoY). Sales on the other hand came in at Rs 29 bn (up 29.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY18); Net Profit Up 50.4% (Quarterly Result Update)

May 28, 2018 | Updated on May 28, 2018

For the quarter ended March 2018, CADILA HEALTHCARE has posted a net profit of Rs 6 bn (up 50.4% YoY). Sales on the other hand came in at Rs 33 bn (up 28.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

This is a Must-Have Stock for Your Portfolio(The 5 Minute Wrapup)

Aug 8, 2018

Tanushree just released the permanent wealth blueprint report. This report includes three safe and steady stocks. I like one in particular. Here's why

Trading in These Times: 8% Gains in 3 Days!(Profit Hunter)

Aug 9, 2018

Here are 2 stocks you can buy right now! And there are plenty more opportunities to come...

Only on WhatsApp, a Weaker Rupee Means a Weaker India(Vivek Kaul's Diary)

Aug 16, 2018

While dollar crossing Rs 70 will have its repercussions, the world isn't exactly coming to an end.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Aug 17, 2018 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - ALKEM LABORATORIES COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS